Related Experiment Video
Updated: Jan 30, 2026

Z-Scores for Assessing Ovarian Reserve in Young Patients Undergoing Fertility Preservation
Published on: October 25, 2024
Can ovarian aging be delayed by pharmacological strategies?
Jinjin Zhang1, Qian Chen1, Dingfu Du1
1Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Abstract:
Aging has been regarded as a treatable condition, and delaying aging could prevent some diseases. Ovarian aging, a special type of organ senescence, is the earliest-aging organ, as ovaries exhibit an accelerated rate of aging with characteristics of gradual declines in ovarian follicle quantity and quality since birth, compared to other organs. Ovarian aging is considered as the pacemaker of female body aging, which drives the aging of multiple organs of the body. Hence, anti-ovarian aging has become a research topic broadly interesting to both biomedical scientists and pharmaceutical industry. A marked progress has been made in exploration of possible anti-ovarian agents or approaches, such as calorie restriction mimetics, antioxidants, autophagy inducers etc., over the past years. This review is attempted to discuss recent advances in the area of anti-ovarian aging pharmacology and to offer new insights into our better understanding of molecular mechanisms underlying ovarian aging, which might be informative for future prevention and treatment of ovarian aging and its related diseases.
Insights
Delaying ovarian aging, the body
Area of Science:
- Gerontology and Reproductive Biology
- Pharmacology of Aging
Background:
- Aging is a treatable condition, with potential for disease prevention.
- Ovarian aging, a unique organ senescence, accelerates from birth, impacting female body aging.
- Ovarian aging is recognized as the pacemaker for systemic aging and multi-organ decline.
Purpose of the Study:
- To review recent advancements in anti-ovarian aging pharmacology.
- To provide insights into the molecular mechanisms of ovarian aging.
- To inform future strategies for preventing and treating ovarian aging and associated diseases.
Main Methods:
- Literature review of pharmacological approaches targeting ovarian aging.
- Analysis of recent research on anti-ovarian aging agents and mechanisms.
- Synthesis of findings on calorie restriction mimetics, antioxidants, and autophagy inducers.
Main Results:
- Significant progress has been made in identifying potential anti-ovarian aging agents.
- Various pharmacological strategies are being explored, including mimetics, antioxidants, and autophagy inducers.
- Understanding molecular pathways is crucial for developing effective interventions.
Conclusions:
- Anti-ovarian aging research is a key area for biomedical scientists and the pharmaceutical industry.
- Continued exploration of molecular mechanisms is essential for therapeutic development.
- Targeting ovarian aging holds promise for delaying overall body aging and related diseases.
More Related Videos
Related Concept Videos
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Ovarian Cycle
The Effect of Aging on Tissues
Cholinergic Antagonists: Pharmacological Actions
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Persuasion Strategies
Changes in the Appendicular Skeleton with Age
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...

